浙江东日股份有限公司 股票交易严重异常波动公告 股票代码： 600113 股票简称：浙江东日 公告编号：2025-034 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 ●公司股票于 2025 年 6 月 16 日至 2025 年 6 月 27 日连续 10 个交易日内日 收盘价格涨幅偏离值累计达到 100%。根据《上海证券交易所交易规则》的相关 规定，属于股票交易严重异常波动情形。 一、 股票交易严重异常波动的具体情况 公司股票于 2025 年 6 月 16 日至 2025 年 6 月 27 日连续 10 个交 易日内日收盘价格涨幅偏离值累计达到 100%。根据《上海证券交易所 交易规则》的相关规定，属于股票交易严重异常波动情形。 ●公司主营业务为农副产品批发交易市场运营管理（含市场交易管理、市场 租赁业务）、生鲜食材配送业务（配菜业务）和豆制品生产加工领域的相关业务。 日常经营不涉及"脑机接口"业务。 截至目前，公司参股公司培安美（浙江）科技股份有限公司未签署任何涉及 "脑机接口"业务相关的合作研发、设备采购、产品 ...

Core Viewpoint - The report details the equity change of Zhejiang Dongri Co., Ltd., highlighting that the information discloser, Duan Xuedong, has increased his shareholding in the company through the secondary market, acquiring a total of 21,091,274 shares, which represents 5.007% of the company's total share capital [1][3][4]. Group 1: Equity Change Details - The equity change was executed by Duan Xuedong, who purchased 6,200,20 shares on June 25, 2025, increasing his total holdings from 20,471,254 shares (4.860%) to 21,091,274 shares (5.007%) [3][4]. - The funding for this equity change was sourced entirely from Duan Xuedong's own funds, ensuring the legality and validity of the transaction [4][6]. - There are no restrictions on the rights associated with the shares acquired in this equity change [4][6]. Group 2: Future Plans and Compliance - Duan Xuedong expresses a positive outlook on the company's value and development prospects, which motivated the equity increase [3]. - There is a possibility of further changes in shareholding within the next 12 months, with a commitment to comply with relevant disclosure obligations if such changes occur [3][6]. - The report confirms that there are no other significant undisclosed matters related to this equity change, ensuring full compliance with regulatory requirements [4][5].

Group 1 - The core point of the announcement is that shareholder Duan Xuedong has increased his stake in Zhejiang Dongri Co., Ltd. to 5.007%, making him a significant shareholder without triggering a mandatory bid [1][1][1] - The increase in shareholding occurred on June 25, 2025, where Duan Xuedong acquired 620,020 shares through centralized trading, raising his total holdings to 21,091,274 shares [1][1][1] - This change in shareholding does not affect the company's controlling shareholder or actual controller, ensuring stability in the company's governance structure and ongoing operations [1][1][1] Group 2 - Prior to the increase, Duan Xuedong held 20,471,254 shares, which accounted for 4.860% of the total share capital [1][1][1] - After the increase, his shareholding percentage rose to 5.007%, indicating a change in the ownership structure but not in control [1][1][1] - The announcement includes a reference to a detailed report on the equity change, which is available for further review [1][1][1]

智通财经6月26日电，浙江东日(600113.SH)公告称，公司收到公司股东段学东出具的《简式权益变动报 告书》。2025年6月25日，股东段学东通过二级市场集中竞价增持公司股份62万股，占公司总股本的 0.147%。本次权益变动后，段学东合计持有公司股份2109.13万股，占公司总股本的5.007%，成为公司 持股5%以上股东。 8天6板浙江东日：股东段学东增持62万股 成为持股5%以上股东 ...

8天6板浙江东日：参股公司培安美未签署任何涉及脑机接口业务相关的书面实质性协议 智通财经6月26日电，浙江东日(600113.SH)公告称，公司关注到市场较为关注"脑机接口"的相关信息。 培安美（浙江）科技股份有限公司原名培安美（浙江）特医食品股份有限公司（简称"培安美"）为我司 参股公司，注册资本1000万元，实收资本1000万元，我司持股比例为40%，成立时间为2024年9月3日。 截至目前，培安美公司未签署任何涉及"脑机接口"业务相关的合作研发、设备采购、产品销售等书面实 质性协议。截至2025年5月底，培安美公司本年累计实现营业收入2.87万元，净利润-66.14万元，对公司 经营业绩影响较小。 ...

截至目前，公司参股公司培安美（浙江）科技股份有限公司未签署任何涉及 "脑机接口"业务相关的合作研发、设备采购、产品销售等书面实质性协议。截 至 2025 年 5 月底，培安美公司本年累计实现营业收入 2.87 万元，净利润-66.14 万元，对公司经营业绩影响较小。 ●根据证监会行业分类，公司所属"租赁和商务服务业"，公司在中证指数 有限公司查询的最新（数据统计至 2025 年 6 月 25 日）行业静态市盈率为 27.93，公司当前（数据统计至 2025 年 6 月 25 日）的最新市盈率为 79.10；截 至 2025 年 6 月 26 日收盘，公司 6 月份股价累计涨幅为 96.82%，远高于行业指 数相关指标。公司股价短期涨幅较大，可能存在炒作风险，敬请投资者注意二级 市场交易风险。 ●经公司自查并向公司控股股东、间接控股股东书面问询确认，不存在应披 露而未披露的重大事项。 ●公司董事会确认，公司日常经营活动正常，不存在影响公司股票交易价格 异常波动的重大事项。 股票代码： 600113 股票简称：浙江东日 公告编号：2025-032 浙江东日股份有限公司 股票交易异常波动公告 本公司董事会及全体董事 ...

股票代码： 600113 股票简称：浙江东日 公告编号：2025-033 浙江东日股份有限公司 关于股东权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 重要内容提示： 本次权益变动属于增持，不触及要约收购。本次权益变动后，公司股东 段学东合计持有本公司股份比例增加至 5.007%，成为本公司持股 5%以上股东。 2025年 6 月26日, 浙江东日股份有限公司（以下简称"浙江东日"或"公 司"）收到公司股东段学东出具的《简式权益变动报告书》。2025年6月25日， 股东段学东通过二级市场集中竞价增持本公司股份620,020股，合计持有本公司 股份21,091,274股,占公司总股本的5.007%，具体情况如下： 一、本次权益变动的基本情况 （一）信息披露义务人基本情况 | 信息披露义务人 | | | --- | --- | | 姓名 | 段学东 | | 身份证号码 | 53011119******** | | 住所 | 云南省昆明市官渡区******** | 截至本公告日，信息披露义务人不存在持有其他境 ...

股票上市地点：上海证券交易所 股票简称：浙江东日 股票代码：600113 浙江东日股份有限公司 简式权益变动报告书 上市公司名称：浙江东日股份有限公司 信息披露义务人一：段学东 住所：云南省昆明市官渡区******** 通讯地址：云南省昆明市官渡区******** 股份变动性质：股份增加 签署日期：2025 年 6 月 26 日 1 信息披露义务人声明 一、本报告书系信息披露义务人根据《中华人民共和国公司法》、《中华人 民共和国证券法》、《上市公司收购管理办法》、《公开发行证券的公司信息披 露内容与格式准则第 15 号——权益变动报告书》及其他相关法律、法规的有关 规定编写。 二、信息披露义务人签署本权益变动报告书已获得必要的授权和批准。 三、依据上述法律、法规的规定，本权益报告书已全面披露了信息披露义务 人在浙江东日股份有限公司拥有权益的股份变动情况。截至本报告书签署之日， 除本报告书披露的信息外，信息披露义务人没有通过任何其他方式增加或减少其 在浙江东日股份有限公司拥有权益的股份。 四、本次权益变动是根据本报告所载明的资料进行的。除信息披露义务人外， 没有委托或者授权任何其他人提供未在本报告中列载的信息和 ...

Group 1 - Retail sector saw a significant afternoon rally with Zhejiang Dongri (600113) hitting the daily limit up [1] - Yinzou Co. (600858) increased by over 7% [1] - Other companies such as Guofang Group (601086), Aiyingshi (603214), and Guoguang Chain (605188) also experienced upward movement [1] Group 2 - Dark pool funds are flowing into these stocks, indicating increased investor interest [1]

Mergers and Acquisitions - Unimed Pharmaceutical announced that its wholly-owned subsidiary, Shanghai Unimed, plans to increase its capital by 45 million yuan to acquire a 51% stake in Sichuan Gokang Pharmaceutical Co., Ltd. After the completion of this transaction, Gokang Pharmaceutical will become a controlled subsidiary of Shanghai Unimed. This transaction does not constitute a related party transaction or a major asset restructuring [1] - BOE Technology Group announced that it has signed a share transfer agreement with Rainbow Co., Ltd. to acquire a 30% stake in Xianyang Rainbow Optoelectronics Technology Co., Ltd. for 4.849 billion yuan [2] - Jianlong Micro-Nano announced that it is planning to acquire at least 51% of Shanghai Hanxing Energy Technology Co., Ltd. through cash payment for equity transfer. Upon completion of this transaction, Jianlong Micro-Nano will become the controlling shareholder of the target company [3] Shareholding Changes - Lishang Guochao announced that its shareholder, Honglou Group Co., Ltd., plans to reduce its holdings by no more than 2.11% of the company's shares, equivalent to a maximum of 16.0764 million shares [4] - Tenglong Co., Ltd. announced that a concerted party of its actual controller, Jiang Yilin, intends to reduce its holdings by no more than 3% of the company's shares, with a maximum of 4.908 million shares through centralized bidding and 9.816 million shares through block trading [5] - Galaxy Microelectronics announced that its major shareholder's concerted parties, Yinjian Investment and Yingu Investment, plan to reduce their holdings by no more than 1.46% of the company's shares, totaling up to 1.8823 million shares. Additionally, director Meng Lang plans to reduce his holdings by no more than 2,250 shares [6] Risk Matters - Zhaofeng Co., Ltd. stated that its current operating conditions are normal and there are no undisclosed significant matters. The company's stock price has experienced an abnormal fluctuation, with a cumulative increase of over 30% in the closing price over three consecutive trading days [7] - Zhejiang Dongri issued a risk warning, clarifying that its daily operations do not involve "brain-computer interface" business. The company has a 40% stake in Peianmei (Zhejiang) Technology Co., Ltd., which has had discussions with Capital Medical University but has not formed a written cooperation agreement [8] - Zhongjing Electronics confirmed that it does not violate information disclosure regulations. The company has experienced an abnormal fluctuation in stock price, with a cumulative increase of over 20% over three consecutive trading days, but its recent operating conditions remain normal [9][10]